Citation 48534

SVOBODA,GH:. (1968). LEUROSINE.. ()

Citation Details

Title	LEUROSINE.
Authors	SVOBODA,GH:
Year	1968
Volume
Issue

Summary

Year: 1968

Journal: Unknown

Organisms and Their Experiments (2)

Catharanthus roseus (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
2	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	INACTIVE
3	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
4	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
5	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
6	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFSYNTHESIS OF ANALOGSWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
7	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
8	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
9	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	INACTIVE
10	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
11	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
12	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	INACTIVE
13	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	INACTIVE
14	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
15	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	ACTIVE
16	ANTITUMOR ACTIVITY	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	INACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFPATENT DESCRIBED	VINDOLINEVINDOLININECATHARANTHINEVINCALEUKOBLASTINEAJMALICINE	None

Catharanthus lanceus (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFWORK DESCRIBED MAINLY CONCERNS METHODOLOGYWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROSINE	None

Show SPARQL Queries (1)